Regeneron Pharmaceuticals, Inc. (REGN) has a market capitalization of $78.5B and trades at $755.51. The 52-week range is 476.49-821.11.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 17.5, Earnings Per Share (EPS) of $43.07, annual revenue of $14.34B.
The stock has a beta of 0.40, a last dividend of $3.5800, operates in the Healthcare sector.
